Importantly, however, the researchers found that visfatin is a predictor of insulin resistance, leading to an improved lipid profile and thus may have a protective function in the development of metabolic syndrome in adolescent female patients with PCOS. The gene discussed is NAMPT; the disease is polycystic ovary syndrome.